Jeff Evanson
2022
In 2022, Jeff Evanson earned a total compensation of $1.4M as Chief Commercial Officer at Outlook Therapeutics, a 370% increase compared to previous year.
Compensation breakdown
| Option Awards | $966,730 |
|---|---|
| Salary | $353,077 |
| Other | $89,154 |
| Total | $1,408,961 |
Evanson received $966.7K in option awards, accounting for 69% of the total pay in 2022.
Evanson also received $353.1K in salary and $89.2K in other compensation.
Rankings
In 2022, Jeff Evanson's compensation ranked 2,366th out of 5,760 executives tracked by ExecPay. In other words, Evanson earned more than 58.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,366 out of 5,760 | 59th |
Division Manufacturing | 1,295 out of 3,136 | 59th |
Major group Chemicals And Allied Products | 576 out of 1,422 | 60th |
Industry group Drugs | 531 out of 1,323 | 60th |
Industry Biological Products, Except Diagnostic Substances | 130 out of 291 | 55th |
Source: SEC filing on February 15, 2023.
Evanson's colleagues
We found two more compensation records of executives who worked with Jeff Evanson at Outlook Therapeutics in 2022.
News
Outlook Therapeutics CEO C Trenary's 2023 pay jumps 32% to $1.8M
February 8, 2024
Outlook Therapeutics Chief Operations Officer Terry Dagnon's 2022 pay jumps 378% to $1.4M
February 15, 2023
Outlook Therapeutics CEO C Trenary receives $7.5M in 2021
January 27, 2022
Outlook Therapeutics CEO Lawrence Kenyon's 2020 pay falls 36% to $1.2M
February 22, 2021